Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mitek and Verigen to market cartilage product:

This article was originally published in Clinica

Executive Summary

German company Verigen and Mitek Worldwide, part of Johnson & Johnson subsidiary Ethicon, are to market an advanced articular cartilage repair system in the US and Canada. Mitek, which develops devices for surgical sports medicine and soft tissue repair, will carry out clinical trials and seek marketing approval. Leverkusen-based Verigen is an autologous biotherapy company specialising in tissue engineering. Its R&D efforts are concentrated on products and procedures for addressing diseases of cartilage, bone and connective tissue.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067005

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel